Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.40 |
| ▸ | CA2 | P00918 | 3/20 | 0.40 |
| ▸ | CA9 | Q16790 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.37 |
| ▸ | SDHB | P21912 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | STAT3 | P40763 | 1/20 | 0.37 |
| ▸ | STAT1 | P42224 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17829433 | 0.81 | CA2 (0.44) | CA1CA2CA9MEN1HPGD | |
| SCHEMBL17829449 | 0.78 | CA2 (0.46) | CA1CA2CA9MEN1HPGD | |
| SCHEMBL17829440 | 0.77 | CA1 (0.43) | CA1CA2CA9MEN1HPGD | |
| SCHEMBL17829442 | 0.77 | CA1 (0.43) | CA1CA2CA9MEN1HPGD | |
| SCHEMBL15850715 | 0.73 | ESR1 (0.61) | MEN1HPGDKMT2ALMNATP53 | |
| SCHEMBL17655916 | 0.73 | ESR1 (0.61) | MEN1HPGDKMT2ALMNATP53 | |
| SCHEMBL25453605 | 0.73 | CA2 (0.44) | CA1CA2CA9MEN1HPGD | |
| SCHEMBL17655915 | 0.72 | CA2 (0.42) | CA1CA2CA9MEN1KMT2A | |
| SCHEMBL21188129 | 0.72 | ESR1 (0.59) | MEN1HPGDKMT2ALMNATP53 | |
| SCHEMBL21188130 | 0.72 | ESR1 (0.59) | MEN1HPGDKMT2ALMNATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10323006-B2 | Heterocyclic compound and organic light emitting element using same | LG CHEM, LTD. (KR) | 2019-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10323006-B2 | Heterocyclic compound and organic light emitting element using same | CRY1, CRY2, NR2E3 | CA1 2920/4885CA2 3796/4885CA9 1855/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.